Tanya Lewis - Mar 1, 2023 Form 3 Insider Report for DiaMedica Therapeutics Inc. (DMAC)

Role
Director
Signature
/s/ Amy E. Culbert, attorney-in-fact
Stock symbol
DMAC
Transactions as of
Mar 1, 2023
Transactions value $
$0
Form type
3
Date filed
3/6/2023, 04:06 PM
Previous filing
May 18, 2022
Next filing
Apr 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DMAC Voting Common Shares, no par value per share 0 Mar 1, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.